Aysen Akkurt Kocaeli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aysen Akkurt Kocaeli has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
Erdınc Erturk
Endocrinology, Uludag University Faculty of Medicine, Bursa, Turkey
3 shared publicationsCanan Ersoy
Endocrinology, Uludag University Faculty of Medicine, Bursa, Turkey
2 shared publications- Dilek Gogas Yavuz
Department of Endocrinology and Metabolism, Marmara University Faculty of Medicine, Istanbul, Turkey
2 shared publications - Emine Kartal Baykan
Department of Endocrinology and Metabolic Diseases, Health Sciences University, Erzurum Faculty of Medicine, Erzurum City Hospital, Erzurum, Turkey
2 shared publications - Filiz Mercan Sarıdaş
Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Bursa Uludağ University, 16059 Bursa, Türkiye
2 shared publications - Filiz Mercantepe
Düzce University
2 shared publications
Latest Publications
- 28 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (11) , 5736-5751
Long-Term Outcomes and Predictors of Recurrent Weight Gain After Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and One Anastomosis Gastric Bypass: Turkish Metabolic and Bariatric Surgery Follow-up Study (TMBS Study)
- 28 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (11) , 5736-5751
Long-Term Outcomes and Predictors of Recurrent Weight Gain After Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and One Anastomosis Gastric Bypass: Turkish Metabolic and Bariatric Surgery Follow-up Study (TMBS Study)
- Open Access
Circulating Long Non-Coding RNAs as a Promising Non-Invasive Tool to Trace Adiposity Capacity Following Obesity Surgery
Background/Aim: Long non-coding RNAs (lncRNAs) such as NEAT1, HULC, and MALAT1, which are expressed in adipose tissue, are known to play a role in regulating adiposity. However, how the plasma expression of these lncRNAs changes in obese patients following rapid adipose tissue loss after sleeve gastrectomy remains unclear. This study aimed to investigate the relationship between plasma NEAT1, HULC, and MALAT1 expression levels and short-term weight loss after sleeve gastrectomy. Materials and Methods: Plasma samples prospectively collected from patient groups were used for total RNA extraction to measure the expression levels of NEAT1, HULC, and MALAT1 both before sleeve gastrectomy and 30 days after the procedure. Additionally, patients were followed for changes in body mass index (BMI) and HbA1C levels over a 12-month period. Associations between lncRNA expression levels and clinical parameters were evaluated. Results: Before sleeve gastrectomy, the expression levels of NEAT1 and HULC were significantly higher in obese patients compared to non-obese individuals (p < 0.0001). Sleeve gastrectomy was associated with decreased expression levels of NEAT1 (p = 0.004) and HULC (p = 0.0027). NEAT1 and HULC expression levels showed significant associations with changes in HbA1C and BMI, respectively (p < 0.05). Conclusions: NEAT1 and HULC expression levels were associated with short-term metabolic and anthropometric changes following sleeve gastrectomy. These findings are exploratory and hypothesis-generating, and further studies with larger cohorts and longer follow-up are needed to determine their potential clinical relevance.
Open AccessCirculating Long Non-Coding RNAs as a Promising Non-Invasive Tool to Trace Adiposity Capacity Following Obesity Surgery
Background/Aim: Long non-coding RNAs (lncRNAs) such as NEAT1, HULC, and MALAT1, which are expressed in adipose tissue, are known to play a role in regulating adiposity. However, how the plasma expression of these lncRNAs changes in obese patients following rapid adipose tissue loss after sleeve gastrectomy remains unclear. This study aimed to investigate the relationship between plasma NEAT1, HULC, and MALAT1 expression levels and short-term weight loss after sleeve gastrectomy. Materials and Methods: Plasma samples prospectively collected from patient groups were used for total RNA extraction to measure the expression levels of NEAT1, HULC, and MALAT1 both before sleeve gastrectomy and 30 days after the procedure. Additionally, patients were followed for changes in body mass index (BMI) and HbA1C levels over a 12-month period. Associations between lncRNA expression levels and clinical parameters were evaluated. Results: Before sleeve gastrectomy, the expression levels of NEAT1 and HULC were significantly higher in obese patients compared to non-obese individuals (p < 0.0001). Sleeve gastrectomy was associated with decreased expression levels of NEAT1 (p = 0.004) and HULC (p = 0.0027). NEAT1 and HULC expression levels showed significant associations with changes in HbA1C and BMI, respectively (p < 0.05). Conclusions: NEAT1 and HULC expression levels were associated with short-term metabolic and anthropometric changes following sleeve gastrectomy. These findings are exploratory and hypothesis-generating, and further studies with larger cohorts and longer follow-up are needed to determine their potential clinical relevance.
- Open Access
- 16 February 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1) , 37
Bone health and fracture risk in diabetes: A multicenter study
Summary: We assessed bone health in over 2500 adults with diabetes across Türkiye. T1DM patients had lower BMD, while T2DM patients showed higher fracture risk despite higher BMD. Several modifiable factors were linked to osteoporosis. These findings support personalized bone assessments in diabetic populations. Background: Diabetes mellitus (DM) is a recognized risk factor for bone fragility. While type 1 DM (T1DM) is typically associated with low bone mineral density (BMD), type 2 DM (T2DM) often presents with higher BMD despite increased fracture risk. Large-scale comparative studies remain limited. Objective: To evaluate bone health, including osteopenia, osteoporosis, and fracture risk, in adults with T1DM and T2DM. Methods: This multicenter, cross-sectional study included 2562 patients (224 with T1DM, 2338 with T2DM) from 27 centers across Türkiye. BMD was assessed using dual-energy X-ray absorptiometry (DXA) and fracture risk was estimated via the Turkish-adapted FRAX® algorithm in patients aged ≥ 40 years. Multinomial logistic regression was used to identify independent predictors of low BMD. Results: Osteoporosis prevalence was 5.5% in T1DM and 9.6% in T2DM (femoral neck T-score). Adjusted BMD was significantly lower in T1DM at all skeletal sites, while FRAX-based fracture risk and fall-related fractures were higher in T2DM. Independent predictors of osteoporosis included older age, female sex, lower BMI, reduced calcium levels, corticosteroid use, albuminuria, hypertension, and less frequent sodium-glucose cotransporter-2 (SGLT2) inhibitor use. T1DM was independently associated with osteopenia but not osteoporosis. Conclusion: This multicenter study demonstrates distinct patterns of BMD and fracture risk across diabetes subtypes and supports individualized bone health assessment in routine diabetes care.
- 16 February 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1) , 37
Open AccessBone health and fracture risk in diabetes: A multicenter study
Summary: We assessed bone health in over 2500 adults with diabetes across Türkiye. T1DM patients had lower BMD, while T2DM patients showed higher fracture risk despite higher BMD. Several modifiable factors were linked to osteoporosis. These findings support personalized bone assessments in diabetic populations. Background: Diabetes mellitus (DM) is a recognized risk factor for bone fragility. While type 1 DM (T1DM) is typically associated with low bone mineral density (BMD), type 2 DM (T2DM) often presents with higher BMD despite increased fracture risk. Large-scale comparative studies remain limited. Objective: To evaluate bone health, including osteopenia, osteoporosis, and fracture risk, in adults with T1DM and T2DM. Methods: This multicenter, cross-sectional study included 2562 patients (224 with T1DM, 2338 with T2DM) from 27 centers across Türkiye. BMD was assessed using dual-energy X-ray absorptiometry (DXA) and fracture risk was estimated via the Turkish-adapted FRAX® algorithm in patients aged ≥ 40 years. Multinomial logistic regression was used to identify independent predictors of low BMD. Results: Osteoporosis prevalence was 5.5% in T1DM and 9.6% in T2DM (femoral neck T-score). Adjusted BMD was significantly lower in T1DM at all skeletal sites, while FRAX-based fracture risk and fall-related fractures were higher in T2DM. Independent predictors of osteoporosis included older age, female sex, lower BMI, reduced calcium levels, corticosteroid use, albuminuria, hypertension, and less frequent sodium-glucose cotransporter-2 (SGLT2) inhibitor use. T1DM was independently associated with osteopenia but not osteoporosis. Conclusion: This multicenter study demonstrates distinct patterns of BMD and fracture risk across diabetes subtypes and supports individualized bone health assessment in routine diabetes care.
- Open Access
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 375-379
Evaluation of Demographic, Clinical, and Radiological Characteristics of Patients with Diabetes in Ischemic Stroke Patients
Ischemic stroke is a common cause of disability and mortality worldwide, and its incidence is increasing in developing countries. Type 2 diabetes is a well-established risk factor for acute ischemic stroke. Diabetes is predicted to be associated with mortality and poor clinical outcomes after ischemic stroke. Diabetes and ischemic stroke are public health problems. This study aims to determine the demographic, clinical, and radiological characteristics of acute ischemic stroke patients with diabetes in our society and to determine the factors affecting ischemic stroke recurrence in patients with diabetes. This study evaluated 862 patients diagnosed with ischemic stroke in Bursa Uludağ University Faculty of Medicine Neurology between 2019 and 2021. Demographic, clinical, and radiological characteristics of the patients were recorded. Factors affecting ischemic stroke recurrence in diabetic and non-diabetic patients were questioned. In this study, risk factors such as coronary artery disease (p<0.01) and hypertension (p<0.01) were observed more frequently in acute ischemic stroke patients with diabetes, and ischemic stroke patients with diabetes had ischemic stroke more often than those without diabetes. It was determined that stroke recurrence (p = 0.003) was observed. Variables associated with ischemic stroke recurrence in ischemic stroke patients with diabetes: A significant statistical association was found with symptomatic atherosclerotic stenosis in the internal carotid artery (p=0.002), anterior circulation stroke (p<0.01), ischemic stroke due to extensive vessel atherosclerosis (p=0.029), and poor clinical outcome (p=0.016). The effect of glycemic control on prognosis and ischemic stroke recurrence in patients with diabetes could not be determined. We recommend that multicenter prospective studies be conducted to determine the relationship between glycemic control and stroke recurrence in diabetic patients. İskemik inme, dünya çapında sakatlık ve mortalitenin yaygın nedenlerinden biridir ve gelişmekte olan ülkelerde görülme sıklığı artmaktadır. Tip 2 diyabet, akut iskemik inme için iyi tanımlanmış bir risk faktörüdür. Diyabetin iskemik inme sonrası mortalite ve kötü klinik sonuçla ilişkili olduğu tahmin edilmektedir. Diyabet ve iskemik inme halk sağlığı sorunlarıdır. Bu çalışmanın amacı toplumumuzdaki diyabetli akut iskemik inme hastalarının demografik klinik ve radyolojik özelliklerini belirlemek ve diyabetli hastalarda iskemik inme rekürrensini etkileyen faktörleri belirlemektir. Bu çalışmada 2019-2021yılları arasında Bursa Uludağ Üniversitesi Tıp Fakültesi Nöroloji bölümünde iskemik inme tanısı alan 862 hasta değerlendirildi. Hastaların demografik, klinik ve radyolojik özellikleri kaydedildi. Diyabetik olan ve olmayan hastaların iskemik inme rekürrensine etki eden faktörler sorgulandı. Bu çalışmada diyabetli akut iskemik inme hastalarında koroner arter hastalığı(p<0.01), hipertansiyon(p<0.01) gibi risk faktörlerinin daha sık görüldüğü, diyabetli iskemik inme hastalarının diyabeti olmayanlara göre daha sık iskemik inme rekürrensi (p=0.003) görüldüğü belirlendi. Diyabetli iskemik inme hastalarında iskemik inme rekürrensi ile ilişkili değişkenler; internal karotid arterde semptomatik aterosklerotik stenoz olması (p=0.002), anterior sirkülasyon inmesinin olması (p<0.01), ve büyük damar aterosklerozuna bağlı iskemik inmesinin olması (p=0.029) ve kötü klinik sonlanım (p=0.016) ile anlamlı istatistiksel ilişkili saptandı. Diyabetli hastalarda glisemik kontrolün prognoza ve iskemik inme rekürrensine etkisi belirlenemedi. Diyabetik hastalarda glisemik kontrolün inme rekürrensi ile ilişkisini belirlemek için çok merkezli prospektif çalışmaların yapılmasını öneriyoruz.
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 375-379
Open AccessEvaluation of Demographic, Clinical, and Radiological Characteristics of Patients with Diabetes in Ischemic Stroke Patients
Ischemic stroke is a common cause of disability and mortality worldwide, and its incidence is increasing in developing countries. Type 2 diabetes is a well-established risk factor for acute ischemic stroke. Diabetes is predicted to be associated with mortality and poor clinical outcomes after ischemic stroke. Diabetes and ischemic stroke are public health problems. This study aims to determine the demographic, clinical, and radiological characteristics of acute ischemic stroke patients with diabetes in our society and to determine the factors affecting ischemic stroke recurrence in patients with diabetes. This study evaluated 862 patients diagnosed with ischemic stroke in Bursa Uludağ University Faculty of Medicine Neurology between 2019 and 2021. Demographic, clinical, and radiological characteristics of the patients were recorded. Factors affecting ischemic stroke recurrence in diabetic and non-diabetic patients were questioned. In this study, risk factors such as coronary artery disease (p<0.01) and hypertension (p<0.01) were observed more frequently in acute ischemic stroke patients with diabetes, and ischemic stroke patients with diabetes had ischemic stroke more often than those without diabetes. It was determined that stroke recurrence (p = 0.003) was observed. Variables associated with ischemic stroke recurrence in ischemic stroke patients with diabetes: A significant statistical association was found with symptomatic atherosclerotic stenosis in the internal carotid artery (p=0.002), anterior circulation stroke (p<0.01), ischemic stroke due to extensive vessel atherosclerosis (p=0.029), and poor clinical outcome (p=0.016). The effect of glycemic control on prognosis and ischemic stroke recurrence in patients with diabetes could not be determined. We recommend that multicenter prospective studies be conducted to determine the relationship between glycemic control and stroke recurrence in diabetic patients. İskemik inme, dünya çapında sakatlık ve mortalitenin yaygın nedenlerinden biridir ve gelişmekte olan ülkelerde görülme sıklığı artmaktadır. Tip 2 diyabet, akut iskemik inme için iyi tanımlanmış bir risk faktörüdür. Diyabetin iskemik inme sonrası mortalite ve kötü klinik sonuçla ilişkili olduğu tahmin edilmektedir. Diyabet ve iskemik inme halk sağlığı sorunlarıdır. Bu çalışmanın amacı toplumumuzdaki diyabetli akut iskemik inme hastalarının demografik klinik ve radyolojik özelliklerini belirlemek ve diyabetli hastalarda iskemik inme rekürrensini etkileyen faktörleri belirlemektir. Bu çalışmada 2019-2021yılları arasında Bursa Uludağ Üniversitesi Tıp Fakültesi Nöroloji bölümünde iskemik inme tanısı alan 862 hasta değerlendirildi. Hastaların demografik, klinik ve radyolojik özellikleri kaydedildi. Diyabetik olan ve olmayan hastaların iskemik inme rekürrensine etki eden faktörler sorgulandı. Bu çalışmada diyabetli akut iskemik inme hastalarında koroner arter hastalığı(p<0.01), hipertansiyon(p<0.01) gibi risk faktörlerinin daha sık görüldüğü, diyabetli iskemik inme hastalarının diyabeti olmayanlara göre daha sık iskemik inme rekürrensi (p=0.003) görüldüğü belirlendi. Diyabetli iskemik inme hastalarında iskemik inme rekürrensi ile ilişkili değişkenler; internal karotid arterde semptomatik aterosklerotik stenoz olması (p=0.002), anterior sirkülasyon inmesinin olması (p<0.01), ve büyük damar aterosklerozuna bağlı iskemik inmesinin olması (p=0.029) ve kötü klinik sonlanım (p=0.016) ile anlamlı istatistiksel ilişkili saptandı. Diyabetli hastalarda glisemik kontrolün prognoza ve iskemik inme rekürrensine etkisi belirlenemedi. Diyabetik hastalarda glisemik kontrolün inme rekürrensi ile ilişkisini belirlemek için çok merkezli prospektif çalışmaların yapılmasını öneriyoruz.
- Open Access
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 313-318
Subacute Thyroiditis Associated with SARS-CoV-2 Vaccines: Pandemic Hospital Experience
Subacute thyroiditis (SAT) is a self-limiting inflammatory disease. This study aimed to describe the characteristics of coronavirus disease 2019 (COVID-19) vaccine-associated subacute thyroiditis cases. Forty-five patients diagnosed before the pandemic period and 19 patients diagnosed with SAT within three months after the COVID-19 vaccine were included in this retrospective study. Demographic, clinical characteristics, laboratory parameters, and ultrasonography findings of the patients were recorded. In addition, the type of vaccines they received, the time until SAT appeared after vaccination, the treatment given, and the response to treatment were evaluated. The demographics, clinical characteristics, laboratory parameters, and treatments they received were similar between the SAT group (Group-1) (n=19) associated with the COVID-19 vaccine and the SAT group (n=45) (Group-2) detected before the pandemic. Only serum C-reactive protein and mean erythrocyte sedimentation rate were higher in Group-2 than in Group-1 (p <0.05). During follow-up, euthyroid cases were detected in 15/19 (78.9%) and 15/45 (33.3%) in Group-1 and Group-2, respectively (p<0.05). There was no difference in relapse rates. SAT was observed in 7 patients after the inactive COVID-19 vaccine and 12 patients after the mRNA COVID-19 vaccine. The median time to symptom onset after vaccination was 11 (4-45) days. As COVID-19 vaccination rates increased during the pandemic, vaccine-related SAT cases became more common. This study showed that COVID-19 vaccine-associated cases have diagnostic features and clinical courses similar to classical SAT. Subakut tiroidit (SAT), kendi kendini sınırlayan inflamatuar bir hastalıktır. Bu çalışma, koronavirüs hastalığı 2019 (COVID-19) aşısıyla ilişkili subakut tiroidit vakalarının özelliklerini tanımlamayı amaçlamıştır. Retrospektif yapılan çalışmaya pandemi dönemi öncesi tanı alan 45 hasta ve COVİD-19 aşısından sonraki üç ay içinde SAT tanısı alan 19 hasta dahil edildi. Hastaların demografik, klinik özellikleri, laboratuvar parametreleri ve ultrasonografi bulguları kaydedildi. Ayrıca yaptırdıkları aşıların türü, aşı sonrası SAT ortaya çıkana kadar geçen süre, verilen tedavi ve tedaviye yanıt değerlendirildi. COVİD-19 aşısı ile ilişkili SAT grubu (Grup-1) (n=19) ile pandemi öncesi saptanan SAT grubunun (n=45) (Grup-2) demografik, klinik özellikleri, laboratuvar parametreleri ve aldıkları tedaviler benzerdi. Sadece serum C-reaktif protein ve ortalama eritrosit sedimantasyon hızı Grup-2’de Grup-1’e göre daha yüksekti (p <0,05). Takip sırasında Grup-1 ve Grup-2’de ötiroid saptanan vakalar sırasıyla 15/19 (%78,9), 15/45 (%33,3) saptandı (p<0.05). Nüks oranları arasında fark yoktu. İnaktif COVID-19 aşısı sonrası 7 hastada, mRNA COVİD-19 aşısı sonrası ise 12 hastada SAT gözlendi. Aşılamadan sonra semptomların başlamasına kadar geçen ortanca süre 11 (4-45) gündü. Pandemi döneminde COVID-19 aşılama oranlarının artmasıyla birlikte aşı ilişkili SAT vakalarına daha sık rastlanmıştır. Bu çalışma, COVİD-19 aşısı ile ilişkili vakaların pandemi dönemi öncesi görülen SAT vakaları ile benzer tanısal özelliklere ve klinik gidişata sahip olduğunu göstermiştir.
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 313-318
Open AccessSubacute Thyroiditis Associated with SARS-CoV-2 Vaccines: Pandemic Hospital Experience
Subacute thyroiditis (SAT) is a self-limiting inflammatory disease. This study aimed to describe the characteristics of coronavirus disease 2019 (COVID-19) vaccine-associated subacute thyroiditis cases. Forty-five patients diagnosed before the pandemic period and 19 patients diagnosed with SAT within three months after the COVID-19 vaccine were included in this retrospective study. Demographic, clinical characteristics, laboratory parameters, and ultrasonography findings of the patients were recorded. In addition, the type of vaccines they received, the time until SAT appeared after vaccination, the treatment given, and the response to treatment were evaluated. The demographics, clinical characteristics, laboratory parameters, and treatments they received were similar between the SAT group (Group-1) (n=19) associated with the COVID-19 vaccine and the SAT group (n=45) (Group-2) detected before the pandemic. Only serum C-reactive protein and mean erythrocyte sedimentation rate were higher in Group-2 than in Group-1 (p <0.05). During follow-up, euthyroid cases were detected in 15/19 (78.9%) and 15/45 (33.3%) in Group-1 and Group-2, respectively (p<0.05). There was no difference in relapse rates. SAT was observed in 7 patients after the inactive COVID-19 vaccine and 12 patients after the mRNA COVID-19 vaccine. The median time to symptom onset after vaccination was 11 (4-45) days. As COVID-19 vaccination rates increased during the pandemic, vaccine-related SAT cases became more common. This study showed that COVID-19 vaccine-associated cases have diagnostic features and clinical courses similar to classical SAT. Subakut tiroidit (SAT), kendi kendini sınırlayan inflamatuar bir hastalıktır. Bu çalışma, koronavirüs hastalığı 2019 (COVID-19) aşısıyla ilişkili subakut tiroidit vakalarının özelliklerini tanımlamayı amaçlamıştır. Retrospektif yapılan çalışmaya pandemi dönemi öncesi tanı alan 45 hasta ve COVİD-19 aşısından sonraki üç ay içinde SAT tanısı alan 19 hasta dahil edildi. Hastaların demografik, klinik özellikleri, laboratuvar parametreleri ve ultrasonografi bulguları kaydedildi. Ayrıca yaptırdıkları aşıların türü, aşı sonrası SAT ortaya çıkana kadar geçen süre, verilen tedavi ve tedaviye yanıt değerlendirildi. COVİD-19 aşısı ile ilişkili SAT grubu (Grup-1) (n=19) ile pandemi öncesi saptanan SAT grubunun (n=45) (Grup-2) demografik, klinik özellikleri, laboratuvar parametreleri ve aldıkları tedaviler benzerdi. Sadece serum C-reaktif protein ve ortalama eritrosit sedimantasyon hızı Grup-2’de Grup-1’e göre daha yüksekti (p <0,05). Takip sırasında Grup-1 ve Grup-2’de ötiroid saptanan vakalar sırasıyla 15/19 (%78,9), 15/45 (%33,3) saptandı (p<0.05). Nüks oranları arasında fark yoktu. İnaktif COVID-19 aşısı sonrası 7 hastada, mRNA COVİD-19 aşısı sonrası ise 12 hastada SAT gözlendi. Aşılamadan sonra semptomların başlamasına kadar geçen ortanca süre 11 (4-45) gündü. Pandemi döneminde COVID-19 aşılama oranlarının artmasıyla birlikte aşı ilişkili SAT vakalarına daha sık rastlanmıştır. Bu çalışma, COVİD-19 aşısı ile ilişkili vakaların pandemi dönemi öncesi görülen SAT vakaları ile benzer tanısal özelliklere ve klinik gidişata sahip olduğunu göstermiştir.
- 6 November 2023
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 56 (02) , 128-133
Bone Mineral Density and Vitamin D Status in Patients with Autoimmune Polyglandular Syndromes: A Single Tertiary Care Center Experience
Immunological abnormalities, the resulting endocrinopathies, and their treatments may impact bone health and 25-hydroxyvitamin D (25-OHD) in patients with autoimmune polyglandular syndromes (APS). Several etiologies contribute to increased risk for low bone mineral density (BMD), including vitamin D deficiency. This study evaluated the vitamin D level and BMD of patients with APS. We performed a cross-sectional study on 44 patients with APS and 55 age and gender-matched control subjects. Among patients with APS, 14 were classified as APS-2 [Addison’s disease (AD)+autoimmune thyroid disease (ATD) and/or type 1 diabetes(T1D)]. In contrast, the other 30 were APS-3 (ATD+T1D+other autoimmune diseases). Serum samples were analyzed for vitamin D levels. The lumbar spine and femoral neck BMD were measured by dual X-ray absorptiometry. Z-scores were obtained by comparison with age- and gender-matched average values (both patients and controls). The accepted normal levels were Z-score>–1 and 25-OHD>30 ng/ml. Patients with APS showed 25-OHD levels and BMD significantly lower than healthy controls (p<0.001 and p<0.05, respectively). The highest prevalence of abnormal BMD was observed in the APS-2 subgroup (13 out of 14 patients, 92.6%). Identifying and treating vitamin D deficiency and low BMD is critical in APS patients. The fact that the significant endocrine component of APS-2 is AD, and these patients receive chronic long-term glucocorticoid therapy can be shown as the reason for this result. However, more extensive prospective controlled studies are needed to confirm these findings.
- 6 November 2023
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 56 (02) , 128-133
Bone Mineral Density and Vitamin D Status in Patients with Autoimmune Polyglandular Syndromes: A Single Tertiary Care Center Experience
Immunological abnormalities, the resulting endocrinopathies, and their treatments may impact bone health and 25-hydroxyvitamin D (25-OHD) in patients with autoimmune polyglandular syndromes (APS). Several etiologies contribute to increased risk for low bone mineral density (BMD), including vitamin D deficiency. This study evaluated the vitamin D level and BMD of patients with APS. We performed a cross-sectional study on 44 patients with APS and 55 age and gender-matched control subjects. Among patients with APS, 14 were classified as APS-2 [Addison’s disease (AD)+autoimmune thyroid disease (ATD) and/or type 1 diabetes(T1D)]. In contrast, the other 30 were APS-3 (ATD+T1D+other autoimmune diseases). Serum samples were analyzed for vitamin D levels. The lumbar spine and femoral neck BMD were measured by dual X-ray absorptiometry. Z-scores were obtained by comparison with age- and gender-matched average values (both patients and controls). The accepted normal levels were Z-score>–1 and 25-OHD>30 ng/ml. Patients with APS showed 25-OHD levels and BMD significantly lower than healthy controls (p<0.001 and p<0.05, respectively). The highest prevalence of abnormal BMD was observed in the APS-2 subgroup (13 out of 14 patients, 92.6%). Identifying and treating vitamin D deficiency and low BMD is critical in APS patients. The fact that the significant endocrine component of APS-2 is AD, and these patients receive chronic long-term glucocorticoid therapy can be shown as the reason for this result. However, more extensive prospective controlled studies are needed to confirm these findings.
- 30 October 2023
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 55 (11) , e7
Correction: Serological Screening for Celiac Disease and Gastrointestinal Absorption Disorders in Patients with Autoimmune Endocrine Diseases
Aysen Akkurt Kocaeli, Soner Cander, Özen Öz Gül, Pınar Sisman, Canan Ersoy, Erdınc Erturk Serological Screening for Celiac Disease and Gastrointestinal Absorption Disorders in Patients with Autoimmune Endocrine Diseases Horm Metab Res 10.1055/a-2156-2773 The first sentence in the section “Study population” has been corrected. Correct is: This prospective, single-center study was conducted at the Internal Medicine and Endocrinology and Metabolism Diseases outpatient clinics of Uludag University Medical Faculty (Bursa, Turkey) between January 2013 and June 2013. Article published online: 07 March 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 30 October 2023
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 55 (11) , e7
Correction: Serological Screening for Celiac Disease and Gastrointestinal Absorption Disorders in Patients with Autoimmune Endocrine Diseases
Aysen Akkurt Kocaeli, Soner Cander, Özen Öz Gül, Pınar Sisman, Canan Ersoy, Erdınc Erturk Serological Screening for Celiac Disease and Gastrointestinal Absorption Disorders in Patients with Autoimmune Endocrine Diseases Horm Metab Res 10.1055/a-2156-2773 The first sentence in the section “Study population” has been corrected. Correct is: This prospective, single-center study was conducted at the Internal Medicine and Endocrinology and Metabolism Diseases outpatient clinics of Uludag University Medical Faculty (Bursa, Turkey) between January 2013 and June 2013. Article published online: 07 March 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 17 August 2023
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 55 (11) , 781-787
Serological Screening for Celiac Disease and Gastrointestinal Absorption Disorders in Patients with Autoimmune Endocrine Diseases
Celiac disease (CD) accompanying autoimmune endocrine diseases (AED) is generally asymptomatic. This study aimed to evaluate the frequency of clinically overt or silent CD in patients diagnosed with autoimmune endocrinopathy and the clinical effects of silent CD in these endocrinopathies. The study included 166 patients with known or newly diagnosed mono-/polyglandular AED and 90 age- and gender-matched healthy controls. The patients were classified into four groups: type 1 diabetes mellitus (DM) (n=44), Hashimoto’s thyroiditis (HT) (n=68), Addison’s disease (AD) (n=17), and autoimmune polyglandular syndrome (APS) (n=37). All subjects were serologically screened for tissue transglutaminase antibody (tTG) IgA and IgG. In addition, to evaluate the possible systemic consequences of CD, serum parathormone (PTH), 25-hydroxicholecalsiferol (25-OH-Vit D), vitamin B12, folic acid, iron, iron-binding capacity (IBC), and ferritin levels were measured. In the total series, 193 (75.4%) individuals were females, and 63 (24.6%) were males. TTG IgA antibody positivity was found in 23 among 166 patients, while no positivity was encountered in the healthy control group. The highest rates of positive tTg IgA frequency were detected in AD, with 29.4% (5/17). Serum 25-OH-Vit D, vitamin B12, folic acid, iron, and ferritin levels were significantly lower in AEDs compared to controls (p<0.001), and the lowest these parameters were detected in patients with AD. The serologic CD prevalence is higher in autoimmune mono-/and polyglandular endocrine diseases than in the control group. The data support recommends regular screening for CD in all patients with AEDs.
- 17 August 2023
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 55 (11) , 781-787
Serological Screening for Celiac Disease and Gastrointestinal Absorption Disorders in Patients with Autoimmune Endocrine Diseases
Celiac disease (CD) accompanying autoimmune endocrine diseases (AED) is generally asymptomatic. This study aimed to evaluate the frequency of clinically overt or silent CD in patients diagnosed with autoimmune endocrinopathy and the clinical effects of silent CD in these endocrinopathies. The study included 166 patients with known or newly diagnosed mono-/polyglandular AED and 90 age- and gender-matched healthy controls. The patients were classified into four groups: type 1 diabetes mellitus (DM) (n=44), Hashimoto’s thyroiditis (HT) (n=68), Addison’s disease (AD) (n=17), and autoimmune polyglandular syndrome (APS) (n=37). All subjects were serologically screened for tissue transglutaminase antibody (tTG) IgA and IgG. In addition, to evaluate the possible systemic consequences of CD, serum parathormone (PTH), 25-hydroxicholecalsiferol (25-OH-Vit D), vitamin B12, folic acid, iron, iron-binding capacity (IBC), and ferritin levels were measured. In the total series, 193 (75.4%) individuals were females, and 63 (24.6%) were males. TTG IgA antibody positivity was found in 23 among 166 patients, while no positivity was encountered in the healthy control group. The highest rates of positive tTg IgA frequency were detected in AD, with 29.4% (5/17). Serum 25-OH-Vit D, vitamin B12, folic acid, iron, and ferritin levels were significantly lower in AEDs compared to controls (p<0.001), and the lowest these parameters were detected in patients with AD. The serologic CD prevalence is higher in autoimmune mono-/and polyglandular endocrine diseases than in the control group. The data support recommends regular screening for CD in all patients with AEDs.